141 related articles for article (PubMed ID: 22948884)
1. Red man syndrome adverse reaction following intravenous infusion of cefepime.
Panos G; Watson DC; Sargianou M; Kampiotis D; Chra P
Antimicrob Agents Chemother; 2012 Dec; 56(12):6387-8. PubMed ID: 22948884
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-induced red man syndrome in pediatric oncology: still an issue?
Bauters T; Claus B; Schelstraete P; Robays H; Benoit Y; Dhooge C
Int J Clin Pharm; 2012 Feb; 34(1):13-6. PubMed ID: 22161495
[TBL] [Abstract][Full Text] [Related]
3. Red man syndrome.
Polk RE
Ann Pharmacother; 1998; 32(7-8):840. PubMed ID: 9681102
[No Abstract] [Full Text] [Related]
4. Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".
Alvarez-Arango S; Ogunwole SM; Sequist TD; Burk CM; Blumenthal KG
N Engl J Med; 2021 Apr; 384(14):1283-1286. PubMed ID: 33830710
[No Abstract] [Full Text] [Related]
5. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Shahar A; Berner Y; Levi S
Ann Pharmacother; 2000 Feb; 34(2):263-4. PubMed ID: 10676837
[No Abstract] [Full Text] [Related]
6. Red man syndrome during administration of prophylactic antibiotic against infective endocarditis.
Ngeow WC; Chai WL; Moody AB
J Ir Dent Assoc; 2000; 46(3):92-4. PubMed ID: 11323942
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electroencephalographic assessment of cefepime during treatment of nosocomial infections in neurological patients.
Alvarez SD; Aragon Mdel C; Moreno A; Palomares-Alonso F; Cook HJ; Cardenas G; Soto-Hernandez JL
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):223-7. PubMed ID: 21919869
[TBL] [Abstract][Full Text] [Related]
8. Oral antihistamines reduce the side effects from rapid vancomycin infusion.
Renz CL; Thurn JD; Finn HA; Lynch JP; Moss J
Anesth Analg; 1998 Sep; 87(3):681-5. PubMed ID: 9728853
[TBL] [Abstract][Full Text] [Related]
9. Selective immediate hypersensitivity to cefepime.
Moreno E; Dávila I; Laffond E; Macías E; Isidoro M; Ruiz A; Lorente F
J Investig Allergol Clin Immunol; 2007; 17(1):52-4. PubMed ID: 17323865
[TBL] [Abstract][Full Text] [Related]
10. Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF; Beringer PM; Louie SG; Synold TW; Gill MA
Antimicrob Agents Chemother; 2003 Jun; 47(6):1991-4. PubMed ID: 12760882
[TBL] [Abstract][Full Text] [Related]
11. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
Rybak MJ; Bailey EM; Warbasse LH
Antimicrob Agents Chemother; 1992 Jun; 36(6):1204-7. PubMed ID: 1384423
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety of teicoplanin and vancomycin.
Wood MJ
J Chemother; 2000 Nov; 12 Suppl 5():21-5. PubMed ID: 11131960
[TBL] [Abstract][Full Text] [Related]
13. Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.
Burgess SV; Mabasa VH; Chow I; Ensom MH
Ann Pharmacother; 2015 Mar; 49(3):311-22. PubMed ID: 25575975
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis.
Wong BB; Ko GJ
Am J Health Syst Pharm; 2003 Nov; 60(21):2229-32. PubMed ID: 14619113
[TBL] [Abstract][Full Text] [Related]
15. Antihistamine prophylaxis permits rapid vancomycin infusion.
Renz CL; Thurn JD; Finn HA; Lynch JP; Moss J
Crit Care Med; 1999 Sep; 27(9):1732-7. PubMed ID: 10507591
[TBL] [Abstract][Full Text] [Related]
16. Histamine release during rapid vancomycin administration.
Renz C; Lynch J; Thurn J; Moss J
Inflamm Res; 1998; 47 Suppl 1():S69-70. PubMed ID: 9561421
[No Abstract] [Full Text] [Related]
17. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.
Healy DP; Sahai JV; Fuller SH; Polk RE
Antimicrob Agents Chemother; 1990 Apr; 34(4):550-4. PubMed ID: 1693055
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin induced cardiac arrest: a case report.
Khakurel S; Rawal S
J Med Case Rep; 2021 Feb; 15(1):77. PubMed ID: 33593409
[TBL] [Abstract][Full Text] [Related]
19. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
[TBL] [Abstract][Full Text] [Related]
20. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.
Wrenn RH; Cluck D; Kennedy L; Ohl C; Williamson JC
J Oncol Pharm Pract; 2018 Apr; 24(3):170-175. PubMed ID: 28077047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
